Showing results (261-270 of 345) with videos related to
Sort By:
Pageof 35
Endocrine-Related Cancer|March 23, 2023
Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosisAnela Blažević, Anand M Iyer, Marie-Louise F van Velthuysen, et al.Neuroendocrinology|July 26, 2016
Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with PegvisomantSanne E Franck, Federico Gatto, Aart Jan van der Lely, et al.European Journal of Endocrinology|May 7, 2020
T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegalyEva C Coopmans, Joppe J Schneiders, Nour El-Sayed, et al.The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Dopamine receptor expression and function in corticotroph pituitary tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.Clinical Endocrinology|April 24, 2004
Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissuesVirgil A S H Dalm, P Martin Van Hagen, Ronald R de Krijger, et al.Endocrinology|January 14, 1999
In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cellsD Ferone, P M van Hagen, P M van Koetsveld, et al.Endocrine-Related Cancer|April 20, 2026
Unravelling Mesenteric Fibrosis in Small Intestinal Neuroendocrine Tumours and Implications for Clinical ManagementMaria Castanho Martins, Eva van der Slik, Johannes Hofland, et al.Oncotarget|January 13, 2016
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinomaClaudia Pivonello, Mariarosaria Negri, Maria Cristina De Martino, et al.Pituitary|November 3, 2025
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas?Nidhi Agrawal, Sonal Mehta, Richard A Feelders, et al.European Journal of Nuclear Medicine|April 1, 1994
A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotideW A Breeman, L J Hofland, M van der Pluijm, et al.Pageof 35